Trial document




drksid header

  DRKS00007729

Trial Description

start of 1:1-Block title

Title

MiniMizer for Sleeve Optimization

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

MISO

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

There are different methods of surgical treatment for obese persons. Sleeve gastrectomy is one of the most common bariatric procedures. In laparoscopic sleeve gastrectomy, the stomach is reduced to a narrow tube which results in a final volume of approximately 100 ml. In average, laparoscopic sleeve gastrectomy allows an excess weight loss of 60 %. However, sleeve dilatation with consecutive weight regain has been observed in some patients. New studies revealed that the implantation of a non-adjustable gastric band may prevent dilatation of the sleeve as a source of treatment failure. The aim of this trial is to investigate, if the additional implantation of a gastric ring improves long-term weight loss after sleeve gastrectomy and prevents dilatation of the gastric sleeve.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

There are different methods of surgical treatment for obese persons. Sleeve gastrectomy is one of the most common bariatric procedures. In laparoscopic sleeve gastrectomy, the stomach is reduced to a narrow tube which results in a final volume of approximately 100 ml. In average, laparoscopic sleeve gastrectomy allows an excess weight loss of 60 %. However, sleeve dilatation with consecutive weight regain has been observed in some patients. New studies revealed that the implantation of a non-adjustable gastric band may prevent dilatation of the sleeve as a source of treatment failure. The aim of this trial is to investigate, if the additional implantation of a gastric ring improves long-term weight loss after sleeve gastrectomy and prevents dilatation of the gastric sleeve.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00007729
  •   2015/01/30
  •   [---]*
  •   yes
  •   Approved
  •   525/14, Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1160-9512 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   E66 -  Obesity
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   laparoscopic sleeve gastrectomy without MiniMizer Ring
  •   laparoscopic sleeve gastrectomy with MiniMizer Ring
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Active control (effective treament of control group)
  •   Treatment
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Weight loss after 36 months

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

HbA1c, number of antidiabetic drugs, blood pressure, number of antihypertension drugs, triglycerides, LDL, HDL, total cholersterol, occurence of reflux, dysphagia, occurence of adverse events, operation time, hosptal stay, Occurence of postsurgical regurgitation after 1, 3, 6, 12 and 36 months, volume of gastric sleeve after 1 and 3 years (MRI)

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • [---]*
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2015/01/31
  •   94
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   19   Years
  •   64   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

->18 and < 65 years, BMI >= 35kg/m2 and existence of obesety-related comorbiditys as there are: type 2 diabetes mellitus, arterial hypertension, sleep apnea, degenerative diseases of the spine or knees, or BMI >=40kg/m2, signed informed consent

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

-history of obesity surgery
-history of major abdominal surgery with resection of the stomach, small and large bowel (exception: appendectomym cholecystectomy, umbilical hernia repair, incisional hernia repair, ingual hernia repair), Patients not eligible to implement silastic ring, history of drug or alcohol abuse, history of major psychiatric illness conflicting with patient´s compliance, lack of compliance, autoimmune disease, inflammatory bowel disease or malabsorptive disease, liver cirrhosis (CHILD A, B, C), active viral or bacterial disease, pregnant women or women with childbearing potential without efficient contraception, history of cancer in the last five years, severe gastroesophageal reflux disease with Barrett´s dysplasia or hiatal hernia >5cm

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Universitätsklinikum Freiburg Abt. Allgemein- und Viszeralchirurgie
    • Mr.  Dr.  Jodok  Fink 
    • Hugstetter Str. 55
    • 79106  Freiburg
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Universitätsklinikum Freiburg Abt. Allgemein- und Viszeralchirurgie
    • Mr.  Dr.  Jodok  Fink 
    • Hugstetter Str. 55
    • 79106  Freiburg
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Universitätsklinikum Freiburg Abt. Allgemein- und Viszeralchirurgie
    • Mr.  Dr.  Jodok  Fink 
    • Hugstetter Str. 55
    • 79106  Freiburg
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Universitätsklinkum Freiburg Abteilung Allgemein- und Viszeralchirurgie
    • Hugstetter Str. 55
    • 79106  Freiburg
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up continuing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.